Receptor density and recycling affect the rate of agonist-induced desensitization of μ-opioid receptor

Molecular Pharmacology

Volumn 58, Issue 2, 2000, Pages 388-398

  Law, Ping Yee ^a,b   Erickson, Laurie J ^a   El Kouhen, Rachid ^a   Dicker, Lee ^a   Solberg, Jonathan ^a   Wang, Wei ^a   Miller, Emilee ^a   Burd, Amy L ^a   Loh, Horace H ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BETA FUNALTREXAMINE; BREFELDIN A; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ETORPHINE; METENKEPHALIN; MONENSIN; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; SUCROSE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENDOCYTOSIS; ENZYME REGULATION; GOLGI COMPLEX; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; KIDNEY CELL CULTURE; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR DENSITY; RECEPTOR SENSITIVITY;

EID: 0033930091     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.2.388     Document Type: Article

References (45)

1. Alblas J, Etten IV, Khanum A and Moolenaar WH (1995) C-terminal truncation of the neurokinin-2 receptor causes enhanced and sustained agonist-induced signaling. J Biol Chem 270:8944-8951.
2. Appleyard SM, Patterson TA, Jin W and Chavkin C (1997) Agonist-induced phosphorylation of the κ-opioid receptor. J Neurochem 69:2405-2412.
3. Arden JR, Segredo V, Wang A, Lameh J and Sadee W (1995) Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged μ-opioid receptor expressed in HEK293 cells. J Neurochem 65:1636-1645.
4. 4 subtype is essential for agonist-induced desensitization. Mol Pharmacol 51:343-349.
5. Beaumont V, Hepworth MB, Luty JS, Kelly E and Henderson G (1998) Somatostatin receptor desensitization in NG10815 cells. A consequence of receptor sequestration. J Biol Chem 273:33174-33183.
6. Capeyrou R, Riond J, Corbani M, Lepage JF, Bertin B and Emorine LJ (1997) Agonist-induced signaling and trafficking of the mu-opioid receptor: Role of serine and threonine residues in the third cytoplasmic loop and C-terminal domain. FEBS Lett 415:200-205.
7. Chaudhry A and Granneman JG (1994) Influence of cell type upon the desensitization of the beta 3-adrenergic receptor. J Pharmacol Exp Ther 271:1253-1258.
8. 3H]β-funaltrexamine covalent binding in the cloned rat μ opioid receptor. J Biol Chem 271:21422-21429.
9. Cheng ZJ, Yu QM, Wu YL, Ma L and Pei G(1998) Selective interference of β-arrestin 1 with κ- and δ-but not μ-opioid receptor/G protein coupling. J Biol Chem 273:24328-24333.
10. Chu P, Murray S, Lissin D and von Zastrow M (1997) Delta and κ-opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist. J Biol Chem 272:27124-27130.
11. Donaldson JG, Finazzi D and Klausner RD (1992) Brefeldin A inhibits Golgi membrane-catalyzed exchange of guanine nucleotide onto ARF protein. Nature (Lond) 360:350-352.
12. Duden R, Griffiths G, Frank R, Argos P and Kreis TE (1991) Beta-COP, a 110 kd protein associated with non-clathrin-coated vesicles and the Golgi complex, shows homology to beta-adaptin. Cell 64:649-665.
13. El-Kouhen R, El-Kouhen OM, Law PY and Loh HH (1999) The absence of a direct correlation between the loss of DAMGO inhibition of adenylyl cyclase activity and agonist-induced mu-opioid receptor phosphorylation. J Biol Chem 274:9207-9215.
14. 2-adrenergic receptor. J Biol Chem 272:13796-13803.
15. Helms JB and Rothman JE (1992) Inhibition by brefeldin A of a Golgi membrane enzyme that catalyses exchange of guanine nucleotide bound to ARF. Nature (Lond) 360:352-354.
16. Hipkin RW, Friedman J, Clark RB, Eppler CM and Schonbrunn A (1997) Agonist-induced desensitization, internalization and phosphorylation of the sst2A somatostatin receptor. J Biol Chem 272:13869-13876.
17. Hipkin RW, Xuebo L and Ascoli M (1995) Truncation of the C-terminal tail of the follitropin receptor does not impair the agonist-or phorbol ester-induced receptor phosphorylation and uncoupling. J Biol Chem 270:26683-26689.
18. Holtmann MH, Roettger BF, Pinon DI and Miller LJ (1996) Role of receptor phosphorylation in desensitization and internalizaton of the secretin receptor. J Biol Chem 271:23566-23571.
19. Keith DE, Murray SR, Zaki PA, Chu Zaki, Lissin DV, Kang L, Evans CJ and von Zastrow M (1996) Morphine activates opioid receptors without causing their rapid internalization. J Biol Chem 271:19021-19024.
20. Kim JY, Soede RDM, Schaap P, Valkema R, Borleis JA, van Haastert PJM, Devreotes PN and Hereld D (1997) Phosphorylation of chemoattractin receptors is not essential for chemotaxis or termination of G-protein-mediated responses. J Biol Chem 272:27313-27318.
21. Koch T, Schulz S, Schroder H, Wolf R, Raulf E and Hollt V (1998) Carboxyl-terminal splicing of the rat μ-opioid receptor modulates agonist-mediated internalization and receptor resensitization. J Biol Chem 273:13652-13657.
22. Koover A, Celver JP, Wu A and Chavkin C (1998) Agonist induced homologous desensitization of μ-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy. Mol Pharmacol 54:704-711.
23. Koover A, Nappey V, Kieffer BL and Chavkin C (1997) Mu and δ-opioid receptors are differentially desensitized by the coexpression of β-adrenergic receptor kinase 2 and β-arrestin 2 in Xenopus oocytes. J Biol Chem 272:27605-27611.
24. Lefkowitz RJ (1998) G-protein coupled receptors III. New roles for receptor kinases and β-arrestins in receptor signaling and desensitization. J Biol Chem 273:18677-18680.
25. Liggett SB, Freedman NJ, Schwinn DA and Lefkowitz RJ (1993) Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor. Proc Natl Acad Sci USA 90:3665-3669.
26. Mollenhauer HH, Morre DJ and Rowe LD (1990) Alteration of intracellular traffic by monensin; mechanism, specificity and relationship to toxicity. Biochim Biophys Acta 1031:225-246.
27. 3-adrenergic receptor is resistant to short term agonist-promoted desensitization. Mol Pharmacol 43:548-555.
28. Pak Y, Kouvelas A, Scheideler MA, Rasmussen J, O'Dowd BF and George SR (1996) Agonist-induced functional desensitization of the μ-opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein. Mol Pharmacol 50:1214-1222.
29. Pak Y, O'Dowd BF and George SR (1997) Agonist-induced desensitization of the μ-opioid receptor is determined by threonine 394 preceded by acidic amino acids in the COOH-terminal tail. J Biol Chem 272:24961-24965.
30. 3 adenosine receptor. J Biol Chem 271:15272-15278.
31. Palmer TM and Stiles GL (1997) Identification of an A2a adenosine receptor domain specifically responsible for mediating short-term desensitization. Biochemistry 36:832-837.
32. Pals-Rylaarsdam R, Xu Y, Witt-Enderby P, Benovic JL and Hosey MM (1995) Desensitization and internalization of the m2 muscarinic acetylcholine receptor are directed by independent mechanisms. J Biol Chem 270:29004-29011.
33. Pei G, Kieffer BL, Lefkowitz RJ and Freedman NJ (1995) Agonist-dependent phosphorylation of the mouse δ-opioid receptor: Involvement of G protein-coupled receptor kinases but not protein kinase C. Mol Pharmacol 48:173-177.
34. Pohl M, Silvente-Poirot S, Pisegna JR, Tarasova NI and Wank SA (1997) Ligand-induced internalization of cholecystokinin receptors. Demonstration of the importance of the carboxyl terminus for ligand-induced internalization of rat cholecystokinin type B receptor but not the type A receptor. J Biol Chem 272:18179-18184.
35. Prather PL, Tsai AW and Law P-Y (1994) Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells. J Pharmacol Exp Ther 270:177-184.
36. Roth A, Kreienkamp HJ, Meyerhof W and Richter D (1997) Phosphorylation of four amino acid residues in the carboxyl terminus of the rat somatostatin receptor sytype 3 is crucial for its desensitization and internalization. J Biol Chem 272: 23769-23774.
37. Takemori AE, Larson DL and Portoghese P (1981) The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone. Eur J Pharmacol 70:445-451.
38. +2-dependent. FEBS Lett 387:53-57.
39. Whistler JL and von Zastrow M (1998) Morphine-activated opioid receptors elude desensitization by β-arrestin. Proc Natl Acad Sci USA 95:9914-9919.
40. Wolf R, Koch T, Schulz S, Hutzny M, Schroder H, Raulf E, Buhling F and Hollt V (1999) Replacement of threonine 394 by alanine facilitates internalization and resensitization of the rat μ-opioid receptor. Mol Pharmacol 55:263-268.
41. Yu Y, Zhang L, Yin X, Sun H, Uhl GR and Wang JB (1997) Mu opioid receptor phosphorylation, desensitization and ligand efficacy. J Biol Chem 272:28869-28874.
42. 2-adrenergic receptor resensitization. Differential regulation of receptor resensitization in two distinct cell types. J Biol Chem 272:27005-27014.
43. Zhang J, Ferguson SSG, Barak LS, Bodduluri S, Laporte S, Law P-Y and Caron MG (1998) Role for G protein-coupled receptor kinase in agonist-specific regulation of μ-opioid receptor responsiveness. Proc Natl Acad Sci USA 95:7157-7162.
44. Zhang L, Yu Y, Mackin S, Weight FF, Uhl GR and Wang JB (1996) Differential mu opiate receptor phosphorylation and desensitization induced by agonists and phorbal ester. J Biol Chem 271:11449-11454.
45. Zimprich A, Simon T and Hollt V (1995) Cloning and expression of an isoform of the rat μ-opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1. FEBS Lett 359:142-146.